Aimmune Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
June 04 2020 - 8:00AM
Business Wire
Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical
company developing and commercializing treatments for potentially
life-threatening food allergies, today announced that the Aimmune
executive management team will participate in a fireside chat at
the Goldman Sachs 41st Annual Global Healthcare Conference on
Tuesday, June 9, 2020 at 11:20 a.m. E.T.
A live webcast of the fireside chat will be accessible in the
Investor Relations section of the Aimmune website at
www.aimmune.com. A replay will be available following the
webcast.
About Aimmune
Aimmune Therapeutics, Inc. is a biopharmaceutical company
developing and commercializing treatments for potentially
life-threatening food allergies. With a mission to improve the
lives of people with food allergies, Aimmune is developing and
commercializing oral treatments for potentially life-threatening
food allergies. The Company’s Characterized Oral Desensitization
ImmunoTherapy (CODIT™) approach is intended to provide meaningful
levels of protection against allergic reactions resulting from
accidental exposure to food allergens by desensitizing patients
with defined, precise amounts of key allergens. Aimmune has one
FDA-approved medicine for peanut allergy, a marketing authorization
application under review with the European Medicines Agency (EMA)
for its investigational medicine for peanut allergy, and other
investigational therapies in development to treat other food
allergies. For more information, please visit www.aimmune.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200604005176/en/
Investors: DeDe Sheel (917) 834-1494
dsheel@aimmune.com
Media: Julie Normart (559) 947-3245
jnormart@w2ogroup.com
Lauren Barbiero (646) 564-2156 lbarbiero@w2ogroup.com
Aimmune Therapeutics (NASDAQ:AIMT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aimmune Therapeutics (NASDAQ:AIMT)
Historical Stock Chart
From Jul 2023 to Jul 2024